Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V 1A receptors

التفاصيل البيبلوغرافية
العنوان: Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V 1A receptors
المؤلفون: Daniel G. Bichet, Christopher Taveau, Lise Bankir, Ronan Roussel, Gilles Guillon, Maithé Corbani, Catherine Chollet, Olle Melander, Gilberto Velho, Nadine Bouby
المساهمون: Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Université Paris Descartes - Paris 5 (UPD5), Hopital du Sacré-Coeur de Montréal, Hôpital du Sacré-Coeur de Montréal, Institut de Génomique Fonctionnelle (IGF), Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Centre National de la Recherche Scientifique (CNRS), Département Hospitalo-Universitaire Fibrosis, Inflammation, Remodeling in cardiovascular, respiratory and renal diseases (Paris), Lund University [Lund], Métabolisme et physiologie rénale (CRC - UMR_S 1138), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-École pratique des hautes études (EPHE)
المصدر: AJP-Endocrinology and Metabolism
AJP-Endocrinology and Metabolism, American Physiological Society, 2017, 312 (3), pp.E127-E135. ⟨10.1152/ajpendo.00269.2016⟩
بيانات النشر: HAL CCSD, 2017.
سنة النشر: 2017
مصطلحات موضوعية: medicine.medical_specialty, Vasopressin, endocrine system, insulin, vasopressin V1A receptor, Physiology, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, [SDV]Life Sciences [q-bio], 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Glucagon, Vasopressin V1a Receptor, 03 medical and health sciences, 0302 clinical medicine, vasopressin V1B receptor, Physiology (medical), Internal medicine, Diabetes mellitus, medicine, Water intake, Receptor, Arginine vasopressin receptor 1B, business.industry, urogenital system, Insulin, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, medicine.disease, glycemia, Endocrinology, nervous system, glucagon, business, hormones, hormone substitutes, and hormone antagonists
الوصف: Recent epidemiological studies have revealed novel relationships between low water intake or high vasopressin (AVP) and the risk of hyperglycemia and diabetes. AVP V1A and V1B receptors (R) are expressed in the liver and pancreatic islets, respectively. The present study was designed to determine the impact of different levels of circulating AVP on glucose homeostasis in normal Sprague-Dawley rats, as well as the respective roles of V1AR and V1BR. We showed that acute injection of AVP induces a dose-dependent increase in glycemia. Pretreatment with a selective V1AR antagonist, but not a V1BR antagonist, dose-dependently prevented the rise in glycemia. V1BR antagonism did not modify the hyperinsulinemic response, resulting from AVP-induced hyperglycemia, but enhanced the fall in glucagonemia. Acute administration of selective V1AR or V1BR agonists confirmed the involvement of V1AR in the hyperglycemic effect of AVP. In chronic experiments, AVP levels were altered in both directions. Sustained AVP infusion through implantable minipumps induced a time-dependent increase in fasting glycemia, whereas lowering endogenous AVP by increasing water intake had no effect. After 4 wk of AVP infusion, the rise in glycemia amounted to 1.1 mmol/l ( P < 0.01) without significant change in insulinemia. This effect was attenuated by cotreatment with a V1AR antagonist. Similar results were observed in lean Zucker rats. These findings demonstrate for the first time a causal link between chronic high AVP and hyperglycemia through V1AR activation and, thus, provide a pathophysiological explanation for the relationship observed in human cohorts between the AVP-hydration axis and the risk of diabetes.
اللغة: English
تدمد: 0193-1849
1522-1555
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::673cc0a18e45962a6951eceee4853d20Test
https://hal.umontpellier.fr/hal-02075391Test
رقم الانضمام: edsair.doi.dedup.....673cc0a18e45962a6951eceee4853d20
قاعدة البيانات: OpenAIRE